share_log

Aurinia Pharmaceuticals: EC Approved Lupkynis for Active Lupus Nephritis >AUPH

Aurinia Pharmaceuticals: EC Approved Lupkynis for Active Lupus Nephritis >AUPH

金銀花製藥:EC批准Lupkynis用於活動性狼瘡性腎炎>AUPH
道瓊斯 ·  2022/09/19 11:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論